Pfizer May Have the Edge Over Moderna In Vaccine Race

Pfizer May Have the Edge Over Moderna In Vaccine Race

Sam Fazeli, Director of Research: EMEA at Bloomberg Intelligence, on the race for a covid vaccine. Brendan Ahern, Chief Investment Officer at KraneShares, on why U.S.-listed Chinese companies are re-listing in Asia. Matt Hawkins, CEO of Entourage Effect Capital, a cannabis-only VC firm, on how PE and VC capital are the only options for many cannabis companies burning thru capital. David Harden, president and CIO of Summit Global Investments, discusses his current investment strategy and stock picks. Hosted by Paul Sweeney and Vonnie Quinn.

See omnystudio.com/listener for privacy information.

Jaksot(3351)

Big Mistake To Not Enlist Europe Against China: Rhodes (Podcast)

Big Mistake To Not Enlist Europe Against China: Rhodes (Podcast)

"Banker to the World" Bill Rhodes, President and CEO of William Rhodes Global Advisors, on the lack of a substantive China trade deal for the U.S. Jason Schenker, President of Prestige Economics and a...

1 Heinä 201931min

GOP Strategist Heye Warns Dems Lurching Too Far Left

GOP Strategist Heye Warns Dems Lurching Too Far Left

Doug Heye, former RNC Communications Director and Republican Strategist, unpacks the second night of Democratic debates.  Maria Considine King, Senior Vice President, Practice Management at Commonweal...

28 Kesä 201926min

Ford Moves In Right Direction With Euro Job Cuts: Kudla

Ford Moves In Right Direction With Euro Job Cuts: Kudla

David Kudla, CEO and Chief Investment Strategist at Mainstay Capital Management, on Ford eliminating 20% of its workforce across Europe. Chris Lu, Former Deputy Secretary of Labor and Senior Fellow at...

27 Kesä 201927min

Little Upside Left in U.S. Junk Bonds: Diamond Hill

Little Upside Left in U.S. Junk Bonds: Diamond Hill

Bill Zox, CIO of Fixed income at Diamond Hill Capital Management, to discuss why there's little upside left in the high yield space. Leland Miller, CEO of China Beige Book International, on China Beig...

26 Kesä 201928min

Allergan Is A Short-Term Cosmetic Fix For AbbVie: Nisen

Allergan Is A Short-Term Cosmetic Fix For AbbVie: Nisen

Max Nisen, Bloomberg Opinion health care columnist, on AbbVie buying Botox maker Allergan for $63 billion. CoinShares Chairman Danny Masters discusses the bitcoin rally and Facebook's new Libra crypto...

25 Kesä 201925min

Private Equity Fees Are Ripe For The ’Vanguard Effect’

Private Equity Fees Are Ripe For The ’Vanguard Effect’

Eric Balchunas, Senior ETF Analyst for Bloomberg Intelligence, on Vanguard considering offering private equity to investors. Francis Greenburger, Time Equities Chairman & CEO, discusses how the recent...

24 Kesä 201927min

Fed's Williams Is Trying to Clean Up Powell's Error (Podcast)

Fed's Williams Is Trying to Clean Up Powell's Error (Podcast)

Phil Orlando, Chief Equity Market Strategist at Federated Investors, on markets, the Fed and current investment strategy.  Clint Watts, Distinguished Research Fellow at the Foreign Policy Research Ins...

21 Kesä 201929min

Slack CEO, CFO On Why They Went With A Direct Listing

Slack CEO, CFO On Why They Went With A Direct Listing

Mandeep Singh, Senior Tech Industry Analyst for Bloomberg Intelligence, on Slack going public in a direct listing, and Slack CEO Stewart Butterfield and CFO Allen Shim speak from the NYSE with Emily C...

20 Kesä 201928min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
herrasmieshakkerit
rss-rahamania
ostan-asuntoja-podcast
taloudellinen-mielenrauha
rss-sami-miettinen-neuvottelija
rahapuhetta
lakicast
rss-startup-ministerio
rss-draivi
sijoitusovi-podcast
rss-h-asselmoilanen
rss-uppoava-vn-laiva
rss-rikasta-elamaa
rss-sisalto-kuntoon
rss-seuraava-potilas
rss-myynnilla-on-asiaa-kert-kenner